The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.

President Trump signed an order to speed federal review of psychedelic drugs for mental health treatment, including plans to fast-track research and approvals.

A pilot program that will allow a chatbot to authorize select psychiatric prescription refills while state regulators suspend ...

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health ...

Jordan Peterson’s condition highlights akathisia, a distressing neurological disorder linked to psychiatric medications, ...

In a major shift for federal drug policy, President Donald Trump signed an executive order on Saturday aimed at accelerating ...

The order instructs the FDA to expedite review of drugs such as ibogaine, a drug that veterans' groups have said can help ...

President Donald Trump signed an executive order Saturday allowing expedited reviews of psychedelic drugs to be used for ...

Would you trust an AI to prescribe you mind-altering psychiatric medication? Amid numerous controversies around chatbot therapy or AI giving bad (or dangerous) medical advice, one healthcare provider ...

The move to ease restrictions into researching the drug are part of a broader push for scientists to study the therapeutic ...

President Donald J. Trump signed an executive order Saturday that will accelerate access to treatments for patients with ...

President Trump has signed an executive order to make certain psychedelic drugs more available to treat mental health ...